These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10951960)

  • 1. [Hospital information systems ineffectiveness in costing ambulatory chemotherapy in pulmonary oncology].
    Thomas P; Raholimina V; Ferri-Dessens RM; Pibarot M; Penot Ragon C; Gregoire R; Kleisbauer JP
    Rev Mal Respir; 2000 Jun; 17(3):659-63. PubMed ID: 10951960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Refining the French system of cost assessment for oncology patients following chemotherapy].
    Lévy-Piedbois C; Borella L; Bergerot P; Peuvrel P; Erard C; Parmentier G; Ravaud A; Trombert Paviot B; Armand JP; Rodrigues JM
    Bull Cancer; 2003 Nov; 90(11):989-96. PubMed ID: 14706903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study based on national DRG data to evaluate work load and practice relating to cancer patients in not-for-profit hospitals].
    Borella L; Peuvrel P; Sauvage M; Maraninchi D; Philip T
    Rev Epidemiol Sante Publique; 2000 Jan; 48(1):53-70. PubMed ID: 10740085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cost of chemotherapy].
    Lévy C; Bonastre J
    Bull Cancer; 2003 Nov; 90(11):976-82. PubMed ID: 14706901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost of medications in the oncology sector in the context of health economics].
    Walter E; Batista A
    Wien Med Wochenschr; 2008; 158(7-8):227-33. PubMed ID: 18500477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient cancer drug costs: changes, drivers, and the future.
    Halbert RJ; Zaher C; Wade S; Malin J; Lawless GD; Dubois RW
    Cancer; 2002 Feb; 94(4):1142-50. PubMed ID: 11920485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adverse effects of anticancer drugs: apropos of a pharmacovigilance study at a specialized oncology institution].
    Couffignal AL; Lapeyre-Mestre M; Bonhomme C; Bugat R; Montastruc JL
    Therapie; 2000; 55(5):635-41. PubMed ID: 11201979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating resource use and cost of prophylactic management of neutropenia with filgrastim.
    Annemans L; Van Overbeke N; Standaert B; Van Belle S
    J Nurs Manag; 2005 May; 13(3):265-74. PubMed ID: 15819840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Program of Medical Information System and diseases of the respiratory tract (CMD, No.4). Study of 1,020 hospital stays out of the total of 18,253 hospitalizations at the Centre Hospitalier de Saint-Gaudens in the framework of the National Study of Costs].
    Vivès L; Biel P; Seitz S; Srour A; Gaillemin C
    Rev Mal Respir; 1997 Sep; 14(4):305-14. PubMed ID: 9411614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
    Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P
    Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nominal and real effects of hospital global budgets in France.
    Redmon DP; Yakoboski PJ
    Inquiry; 1995; 32(2):174-83. PubMed ID: 7601515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two or three things about the PMSI in stomatology and maxillofacial surgery].
    Boutault F; Dodart L; Gas C; Paoli JR; Lauwers F; Chale JJ
    Rev Stomatol Chir Maxillofac; 1999 Dec; 100(6):279-87. PubMed ID: 10672646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain.
    Mapel DW; Shainline M; Paez K; Gunter M
    J Rheumatol; 2004 Mar; 31(3):573-83. PubMed ID: 14994407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The costs of extreme values and case resolved in a public hospital from Iaşi, Romania].
    Bogdănici C; Bârliba I
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):466-70. PubMed ID: 19295021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France.
    Horvais V; Touzet S; François S; Bourdy S; Bellon G; Colin C; Durieu I
    Int J Technol Assess Health Care; 2006; 22(4):525-31. PubMed ID: 16984688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoracic aortic aneurysm repair. Direct hospital cost and Diagnosis Related Group reimbursement.
    Mishra V; Geiran O; Krohg-Sørensen K; Andresen S
    Scand Cardiovasc J; 2008 Feb; 42(1):77-84. PubMed ID: 18273734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality of medical database to valorize the DRG model by ISA cost indicators].
    Holstein J; Taright N; Lepage E; Razafimamonjy J; Duboc D; Feldman L; Hittinger L; Lavergne T; Chatellier G
    Rev Epidemiol Sante Publique; 2002 Dec; 50(6):593-603. PubMed ID: 12515929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality assessment of the medical information on the standardized discharge summary].
    Vergnon P; Morgon E; Dargent S; Benyamine D; Favre M; Perrot L; Pradat E; Colin C
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):24-33. PubMed ID: 9533231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.
    Bennett CL; Calhoun EA
    Oncologist; 2007 Apr; 12(4):478-83. PubMed ID: 17470690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.